Co-Diagnostics and ReadyGo to test blood-based Ebola detection
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola
September 16, 2026 8:45 AM EDTBlood-based testing could open new markets for the Co-Dx® PCR platform, including HIV and hepatitis B and C
Co-Diagnostics and ReadyGo target decentralized Ebola detection as the first application of their collaboration
Combining GoCollect® sample preparation with Co-Dx PCR technology could bring blood-based molecular testing closer to patients
Company to hold in-person press conference and live webcast today at 10:30 a.m. ET
... More